LumiMeds

What it is

Describes itself as a patient management platform working with independent physicians.

Plans include provider review, medication and free shipping, with 24/7 care-team messaging.

Also sells NAD+ plans.

LumiMeds offers compounded NAD+ injections from $133/month, with monthly, 3-month and 6-month options.

It names Olympia, an FDA-registered 503B outsourcing pharmacy, as the source.

No membership is required, FSA/HSA is accepted and there is a full refund if not eligible.

The site says sermorelin is coming soon and that compounded medications are not FDA-approved.

Prescribes: Compounded semaglutide and tirzepatide (site states not FDA-approved) Compounded NAD+ (not FDA-approved) and compounded or brand GLP-1s.

What it costs

Insurance: No insurance mentioned; accepts FSA/HSA and payment plans.

Prices change often. Check lumimeds.com before you sign up.

By the numbers

• Trustpilot 4.7/5 from 1,045 reviews (7% 1-star; checked 2026-10-15).4

Pros and cons

What users say

Common themes in public posts on Reddit, Trustpilot, the Better Business Bureau and app stores, summarised and linked. Individual experiences vary.

• Reviewers often mention responsive staff, follow-up calls and fast shipping.2
• Some reviewers report trouble reaching a live representative, refund friction or portal order issues.2
• LumiMeds became popular in r/tirzepatidecompound in mid-2025 for low-priced deals on compounded tirzepatide from a well-regarded outsourcing pharmacy, and its staff post program updates in the subreddit.56
• After that supply ran out in August 2025, members reported a price rise to about $349 a month, a pharmacy change, and long waits; one first-time order was still not delivered two months later.789
• Members also criticise a confusing two-site ordering process and slow email or web support.58
• Trustpilot reviewers praise helpful, prompt staff and fast shipping; complaints mention refund trouble, portal problems with orders and results below expectations.4
• Trustpilot reviewers frequently mention responsive staff and fast shipping.2
• Some report slow access to a live representative, refund friction and portal order glitches; no reviews seen mention NAD+.2

Records we found

Official and court records we found in public sources as of October 15, 2026. This is not a live or complete record; check fda.gov, ftc.gov and court sites for the latest.

1. Sep 2025
   FDA

   FDA sent a warning letter stating claims about its compounded semaglutide and tirzepatide (including same-active-ingredient claims) were false or misleading under FDCA 502(a) and 502(bb).3

2. Sep 2025
   FDA

   FDA warning letter stating claims about compounded semaglutide and tirzepatide were false or misleading (not about NAD+).3